TAP Consulting’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

TAP Consulting’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$1.86M	Buy	11,211 +2,658	+31%	+$454K	0.38%	76
2024 Q3	$1.47M	Sell	8,553 -4,209	-33%	-$697K	0.29%	85
2024 Q2	$1.97M	Buy	12,762 +1,441	+13%	+$216K	0.41%	72
2024 Q1	$1.74M	Buy	+11,321	New	+$1.73M	0.38%	76
2023 Q4	–	Sell	-10,384	Closed	-$1.52M	–	130
2023 Q3	$1.52M	Buy	10,384 +1,356	+15%	+$207K	0.39%	76
2023 Q2	$1.38M	Buy	+9,028	New	+$1.41M	0.34%	77

Other funds holding FBT

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

CAG

Csenge Advisory Group Clearwater, Florida $2.47B AUM 24.93% 1-Year Est. Return

TAP Consulting's FBT Position: Q4 2024 in Review

TAP Consulting increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 31% in Q4 2024, buying an estimated $454K and bringing the position to 11,211 shares worth $1.86M. The position accounts for 0.38% of the portfolio, ranked #76.

TAP Consulting first reported a position in FBT in Q2 2023 and has held it in 6 quarters since. The position peaked at $1.97M in Q2 2024. 256 funds tracked by Wall St. Rank hold FBT as of Q4 2024.

TAP Consulting held 11,211 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.86M as of Q4 2024.
TAP Consulting bought 2,658 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2024, an estimated $454K.
First Trust NYSE Arca Biotechnology Index Fund made up 0.38% of TAP Consulting's portfolio in Q4 2024, its #76 holding.
TAP Consulting first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2023 and has held it in 6 quarters since.
TAP Consulting's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.97M in Q2 2024.
256 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2024.

Based on TAP Consulting's 13F filing for Q4 2024, filed 11 Feb 2025.